AXR.NYSEAmrep CORP

Form 4: AMREP Director Albert Russo Receives Stock Units

Sentiment:

Insider Transaction Report


AMREP Corporation director Albert Russo was granted 1,595 deferred stock units, vesting immediately, as part of his compensation.

Summary

  • AMREP Corporation director Albert Russo was granted 1,595 deferred stock units on December 31, 2025.
  • These units vest immediately upon grant.
  • Each deferred stock unit represents the right to receive one share of AMREP's common stock.
  • The shares will be distributed to Mr. Russo within 30 days after the first day of the month following his termination of service as a director.
  • Following this transaction, Mr. Russo beneficially owns 24,408.56 deferred stock units.
  • A Power of Attorney was executed on October 8, 2025, appointing Christopher V. Vitale and Adrienne M. Uleau as attorneys-in-fact for Mr. Russo to handle SEC filings.

Sentiment

Score: 6

Explanation: The filing reports a routine compensation grant to a director, which is a neutral to slightly positive event as it aligns director interests with shareholders. No significant positive or negative financial implications for the company are immediately apparent from this specific transaction.

Positives

  • Director Albert Russo received 1,595 deferred stock units, aligning his interests with shareholders.
  • The deferred stock units vest immediately upon grant, providing immediate beneficial ownership.

Negatives

  • No specific negatives are identified in this routine compensation filing.

Risks

  • The reporting person (Albert Russo) acknowledges that the attorneys-in-fact and AMREP Corporation are not assuming his responsibilities to comply with Section 16 of the Exchange Act.
  • Albert Russo agrees to indemnify and hold harmless AMREP Corporation and the attorneys-in-fact against losses, claims, damages, or liabilities arising from untrue statements or omissions in information he provides for SEC filings.

Future Outlook

The deferred stock units granted to Director Albert Russo will be distributed as common stock within 30 days after the first day of the month following his termination of service as a director.

Industry Context

This Form 4 filing details a routine insider transaction, specifically the grant of deferred stock units to a director as part of their compensation. Such grants are common practice across various industries to align the interests of company leadership with those of shareholders.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney GrantAlbert V. Russo granted a Power of Attorney to Christopher V. Vitale and Adrienne M. Uleau to prepare and file SEC Forms 4 and 5 on his behalf, ensuring compliance with Section 16 of the Exchange Act.2025-10-08Streamlines the process for Mr. Russo's SEC compliance filings, delegating administrative tasks while retaining ultimate responsibility.

Related Party Transactions

  • The grant of 1,595 deferred stock units to Albert Russo, a director of AMREP Corporation, constitutes a related party transaction as it involves compensation provided by the company to an insider.

Stakeholder Impact

  • Shareholders: The grant of deferred stock units to a director aligns the director's long-term interests with those of the shareholders, potentially encouraging decisions that enhance shareholder value.
  • Director (Albert Russo): Receives additional equity compensation, increasing his beneficial ownership in the company.

Next Steps

  • Distribution of common stock shares to Albert Russo within 30 days after the first day of the month following his termination of service as a director.

Key Dates

DateDescription
2025-10-08Date Power of Attorney was executed by Albert V. Russo.
2025-12-31Date of the transaction where Albert Russo was granted deferred stock units.
2026-01-05Date the Form 4 was signed by the attorney-in-fact for Albert Russo.
2027-10-06Expiration date of Notary Public Lydia Y. Mann's commission.

Recommendation

hold

This Form 4 filing details a routine grant of deferred stock units to a director as part of their compensation. While it aligns insider interests with shareholders, it does not provide sufficient new information regarding the company's operational performance, financial health, or strategic direction to warrant a change in investment recommendation based solely on this disclosure. It is a standard compliance filing.

Keywords

AMREP Corporation, AXR, Albert Russo, Form 4, Deferred Stock Units, Director Compensation, Insider Transaction, Equity Grant, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.